| scholarly article | Q13442814 |
| P50 | author | Thomas Tuschl | Q90093 |
| Sara H Rouhanifard | Q83173599 | ||
| Eric C Holland | Q89747805 | ||
| Reuven Agami | Q30502648 | ||
| Cameron Brennan | Q30502649 | ||
| P2093 | author name string | Carlos le Sage | |
| Jason T Huse | |||
| Dolores Hambardzumyan | |||
| Cherin Sohn-Lee | |||
| Boyoung Wee | |||
| John Pena | |||
| P2860 | cites work | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 |
| MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation | Q24679746 | ||
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Widespread changes in protein synthesis induced by microRNAs | Q27860886 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma | Q40407116 | ||
| Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma | Q42013793 | ||
| Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis | Q42827324 | ||
| PTEN methylation and expression in glioblastomas | Q48232099 | ||
| MicroRNAs and cancer | Q48324133 | ||
| High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model | Q48456290 | ||
| PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. | Q55474170 | ||
| The retinoblastoma gene is involved in malignant progression of astrocytomas | Q72853950 | ||
| MicroRNA signatures in human ovarian cancer | Q28249211 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 | ||
| Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor | Q28264817 | ||
| MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis | Q28269041 | ||
| microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma | Q28280337 | ||
| MYC stimulates EZH2 expression by repression of its negative regulator miR-26a | Q28291303 | ||
| Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma | Q28304953 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors | Q29614399 | ||
| Ribo-gnome: the big world of small RNAs | Q29615681 | ||
| MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN | Q29616575 | ||
| Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
| Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells | Q33715154 | ||
| MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells | Q34842477 | ||
| PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo | Q35080265 | ||
| A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice | Q35211546 | ||
| PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis | Q35746631 | ||
| Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice | Q35801259 | ||
| Mechanisms of common fragile site instability. | Q36294681 | ||
| An update on oligodendroglial neoplasms | Q36310485 | ||
| PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo | Q36453531 | ||
| Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. | Q36572080 | ||
| Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome | Q36718983 | ||
| Structural alterations of the epidermal growth factor receptor gene in human gliomas | Q36930689 | ||
| MicroRNAs | Q37095827 | ||
| Pten haploinsufficiency accelerates formation of high-grade astrocytomas | Q37384874 | ||
| MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
| miRNA in situ hybridization in formaldehyde and EDC-fixed tissues | Q39612232 | ||
| Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas | Q39996274 | ||
| MicroRNA-21 targets tumor suppressor genes in invasion and metastasis | Q40013848 | ||
| MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas | Q40073679 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 1327-37 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Genes & Development | Q1524533 |
| P1476 | title | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | |
| P478 | volume | 23 |
| Q38637596 | A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease |
| Q24632651 | A coding-independent function of gene and pseudogene mRNAs regulates tumour biology |
| Q34631552 | A continuum model for tumour suppression |
| Q31016573 | A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). |
| Q38356196 | A major role for microRNAs in glioblastoma cancer stem-like cells |
| Q42230002 | A miRNA expression signature that separates between normal and malignant prostate tissues. |
| Q39670048 | A microRNA Link to Glioblastoma Heterogeneity |
| Q24633772 | A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion |
| Q33869822 | A ten-microRNA expression signature predicts survival in glioblastoma |
| Q53079070 | AKT kinase pathway: a leading target in cancer research. |
| Q57161414 | Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma |
| Q37089505 | Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC |
| Q40498643 | Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. |
| Q37226756 | Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon |
| Q27005597 | Adeno-associated virus-mediated microRNA delivery and therapeutics |
| Q34061489 | Adult-specific functions of animal microRNAs |
| Q90570508 | Alternative polyadenylation confers Pten mRNAs stability and resistance to microRNAs |
| Q49023583 | Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors. |
| Q37847257 | Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma |
| Q47571295 | Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model. |
| Q37736273 | Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma |
| Q42478581 | Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells |
| Q35388292 | Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma. |
| Q57284763 | Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer |
| Q35422357 | CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells |
| Q39675624 | CPEB2, CPEB3 and CPEB4 are coordinately regulated by miRNAs recognizing conserved binding sites in paralog positions of their 3'-UTRs |
| Q64083820 | Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axis |
| Q38189403 | Cellular Response to Ionizing Radiation: A MicroRNA Story |
| Q35651246 | Cellular microRNA miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by activating innate antiviral immunity |
| Q41615120 | Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics |
| Q45673083 | Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor-suppressive miR-124. |
| Q42039758 | Circulating Plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS). |
| Q38776396 | Circulating microRNAs in acute and chronic exercise: more than mere biomarkers |
| Q34508976 | Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment |
| Q39160992 | Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma |
| Q24629589 | Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs |
| Q50420455 | Cohesive Regulation of Neural Progenitor Development by microRNA miR-26, Its Host Gene Ctdsp and Target Gene Emx2 in the Mouse Embryonic Cerebral Cortex. |
| Q48470503 | Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ |
| Q64253022 | Comparison of the Transcriptomes and Proteomes of Serum Exosomes from Marek's Disease Virus-Vaccinated and Protected and Lymphoma-Bearing Chickens |
| Q41136585 | Comprehensive analysis of microRNA expression profile in malignant glioma tissues |
| Q26996848 | Connecting the dots between tau dysfunction and neurodegeneration |
| Q39177304 | Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs |
| Q34416068 | Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. |
| Q38259629 | Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2. |
| Q38034755 | Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme |
| Q38102611 | Current progress for the use of miRNAs in glioblastoma treatment |
| Q42115145 | Decoding the cancer stem cell hypothesis in glioblastoma |
| Q64067528 | Deregulated MicroRNA Signature Following Glioblastoma Irradiation |
| Q38057886 | Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview. |
| Q28534050 | Developmental and activity-dependent miRNA expression profiling in primary hippocampal neuron cultures |
| Q92253114 | Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma |
| Q92840399 | Downregulation of serum miR-26a predicts poor clinical outcome of papillary thyroid carcinoma |
| Q37961805 | Epigenetic architecture and miRNA: reciprocal regulators. |
| Q91712007 | Estrogen Reverses HDAC Inhibitor-Mediated Repression of Aicda and Class-Switching in Antibody and Autoantibody Responses by Downregulation of miR-26a |
| Q45613688 | Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors |
| Q64259621 | Exploration of miRNA and mRNA Profiles in Fresh and Frozen-Thawed Boar Sperm by Transcriptome and Small RNA Sequencing |
| Q48090086 | Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients. |
| Q41135067 | Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. |
| Q35043317 | Expression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway. |
| Q53078040 | Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. |
| Q26797287 | Focus on PTEN Regulation |
| Q35010133 | Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro |
| Q28267167 | Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway |
| Q34203950 | Genetic alterations in microRNAs in medulloblastomas |
| Q37955107 | Genetic alterations of PTEN in human melanoma |
| Q48089491 | Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma |
| Q34257360 | Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. |
| Q38606228 | Genomic integrity and the ageing brain |
| Q38207605 | Glioblastoma stem cells: Molecular characteristics and therapeutic implications |
| Q39005215 | Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. |
| Q38460865 | Glioblastoma: pathology, molecular mechanisms and markers |
| Q24631473 | Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype |
| Q34115364 | HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway |
| Q92921699 | High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network |
| Q58719119 | High miR-718 Suppresses Phosphatase and Tensin Homolog (PTEN) Expression and Correlates to Unfavorable Prognosis in Gastric Cancer |
| Q37492187 | High-throughput microRNA profiling of pediatric high-grade gliomas. |
| Q37065678 | How genetically engineered mouse tumor models provide insights into human cancers |
| Q34140925 | Human traumatic brain injury alters plasma microRNA levels. |
| Q35319936 | Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway |
| Q37269137 | Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts. |
| Q47575408 | Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model |
| Q38432744 | Identification and functional analysis of the risk microRNAs associated with cerebral low-grade glioma prognosis |
| Q92366540 | Identification and validation of mRNA 3'untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN |
| Q36733776 | Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia |
| Q36295318 | Identification of global alteration of translational regulation in glioma in vivo |
| Q37366610 | Improved Adeno-associated Viral Gene Transfer to Murine Glioma. |
| Q34030947 | Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes |
| Q39692548 | Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation. |
| Q33719798 | Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship |
| Q36552755 | Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients |
| Q26770381 | Interplay Between Metabolism and Oncogenic Process: Role of microRNAs |
| Q34393758 | Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses |
| Q24608490 | Intronic miR-26b controls neuronal differentiation by repressing its host transcript, ctdsp2 |
| Q39615360 | Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line |
| Q39007424 | KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway |
| Q38745227 | KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer |
| Q61800908 | Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology |
| Q64055134 | Limits Muscle Wasting and Cardiac Fibrosis through Exosome-Mediated microRNA Transfer in Chronic Kidney Disease |
| Q37636621 | Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastoma |
| Q33744534 | Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies |
| Q34547703 | Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells. |
| Q35627069 | MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma |
| Q36757035 | MiR-26a Rescues Bone Regeneration Deficiency of Mesenchymal Stem Cells Derived From Osteoporotic Mice |
| Q38750019 | MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. |
| Q37046835 | MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. |
| Q38706042 | MiR-26a downregulates retinoblastoma in colorectal cancer. |
| Q36080088 | MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury. |
| Q45012413 | MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated |
| Q34764211 | MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1 |
| Q37505913 | MiR-26a promotes ovarian cancer proliferation and tumorigenesis |
| Q92917167 | MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN/PI3K/AKT pathway |
| Q37261417 | MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons |
| Q39519803 | MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation |
| Q89880080 | Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme |
| Q37981156 | MicroRNA Control of Invasion and Metastasis Pathways |
| Q41208796 | MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma. |
| Q53137197 | MicroRNA and cancer. |
| Q37706077 | MicroRNA control of signal transduction |
| Q34409620 | MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. |
| Q37420580 | MicroRNA in Human Glioma |
| Q37619633 | MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b |
| Q34793627 | MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response |
| Q34185623 | MicroRNA sequence and expression analysis in breast tumors by deep sequencing |
| Q54284943 | MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. |
| Q38731400 | MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells |
| Q39196866 | MicroRNA-153 is tumor suppressive in glioblastoma stem cells. |
| Q38715688 | MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase |
| Q48381555 | MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma |
| Q36202394 | MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling |
| Q24633326 | MicroRNA-182-5p targets a network of genes involved in DNA repair |
| Q34436329 | MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN). |
| Q64233019 | MicroRNA-20b promotes proliferation of H22 hepatocellular carcinoma cells by targeting PTEN |
| Q35032496 | MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma |
| Q41856145 | MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1. |
| Q35145305 | MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer |
| Q24624403 | MicroRNA-26a is a novel regulator of vascular smooth muscle cell function |
| Q35273569 | MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin |
| Q39123359 | MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin |
| Q33807718 | MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells |
| Q47616223 | MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway |
| Q36433424 | MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. |
| Q46255425 | MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway |
| Q42290877 | MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia |
| Q93185200 | MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma |
| Q40647567 | MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines. |
| Q38714023 | MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines |
| Q36304803 | MicroRNA-26b Modulates the NF-κB Pathway in Alveolar Macrophages by Regulating PTEN. |
| Q61443739 | MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma |
| Q33843200 | MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog |
| Q89475347 | MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells |
| Q46190130 | MicroRNA-target cross-talks: Key players in glioblastoma multiforme |
| Q55460934 | MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors. |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q37857375 | MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications |
| Q37897499 | MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme |
| Q35832148 | MicroRNAs in apoptosis, autophagy and necroptosis |
| Q26865287 | MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells |
| Q34760006 | MicroRNAs in cardiac disease |
| Q26747273 | MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics |
| Q34325959 | MicroRNAs in human cancer |
| Q39446959 | MicroRNAs in mucosal inflammation. |
| Q37974078 | MicroRNAs in neural cell development and brain diseases |
| Q27027517 | MicroRNAs in stress signaling and human disease |
| Q38097384 | MicroRNAs involved in chemo- and radioresistance of high-grade gliomas |
| Q37917655 | MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas |
| Q35388050 | MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals |
| Q28657834 | MicroRNAs: history, biogenesis, and their evolving role in animal development and disease |
| Q35135542 | MicroRNAs: new players in IBD. |
| Q27027998 | MicroRNAs: promising new antiangiogenic targets in cancer |
| Q37833881 | MicroRNAs: redefining mechanisms in cardiac disease |
| Q64234430 | Micromanaging aerobic respiration and glycolysis in cancer cells |
| Q36272539 | Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact |
| Q38280833 | Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model |
| Q34469322 | Modulation of the osteosarcoma expression phenotype by microRNAs |
| Q38465854 | Molecular targets in glioblastoma |
| Q34083282 | Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma |
| Q92906114 | Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions |
| Q39000847 | Mutant IDH1 inhibits PI3K/Akt signaling in human glioma. |
| Q35640345 | Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms |
| Q37614231 | NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism. |
| Q38604713 | New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway |
| Q26823718 | Noncoding RNA in oncogenesis: a new era of identifying key players |
| Q26864697 | Noncoding RNAs in DNA repair and genome integrity |
| Q30413140 | Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim. |
| Q33579323 | Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model |
| Q36778838 | Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions |
| Q59123158 | OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers |
| Q36898111 | Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival |
| Q36375834 | PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma |
| Q45314383 | PI3K/AKT Signaling in Cancer |
| Q39584693 | PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs |
| Q45314387 | PTEN Loss of Function in Cancer |
| Q45318299 | PTEN Regulation |
| Q36452913 | PTEN at a glance |
| Q53601178 | PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma. |
| Q35056451 | PTEN is a negative regulator of NK cell cytolytic function. |
| Q37856722 | PTEN loss in the continuum of common cancers, rare syndromes and mouse models. |
| Q50299118 | PTEN mRNA translation is negatively regulated by microRNAs |
| Q50290154 | PTEN mRNA translation negatively regulated by microRNAs |
| Q38738670 | PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients |
| Q27011088 | PTEN regulation of ERK1/2 signaling in cancer |
| Q28295895 | Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer |
| Q58766575 | Phenotypic miRNA Screen Identifies miR-26b to Promote the Growth and Survival of Endothelial Cells |
| Q47127377 | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. |
| Q36504138 | Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population |
| Q59333218 | Potential Epigenetic-Based Therapeutic Targets for Glioma |
| Q55463671 | Potential role of miRNAs and their inhibitors in glioma treatment. |
| Q34159409 | Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. |
| Q48473937 | Profile of microRNA expression in brain tumors of different malignancy |
| Q64116760 | Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis |
| Q34238901 | Prognostic significance of miR-205 in endometrial cancer |
| Q37584292 | Prospects of miRNA-based therapy for pancreatic cancer |
| Q64245074 | Protein Phosphatases-A Touchy Enemy in the Battle Against Glioblastomas: A Review |
| Q37638344 | Protein tyrosine phosphatases in glioma biology |
| Q24632928 | Recent advances in the molecular understanding of glioblastoma |
| Q34017894 | Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene |
| Q33732748 | Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486 |
| Q45318301 | Regulation of PTEN mRNA translation |
| Q35140496 | Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis |
| Q36152814 | Retracted: MicroRNA-20b (miR-20b) Promotes the Proliferation, Migration, Invasion, and Tumorigenicity in Esophageal Cancer Cells via the Regulation of Phosphatase and Tensin Homologue Expression |
| Q34825705 | Retracted: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma |
| Q37617262 | Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment |
| Q36797902 | Role of MicroRNAs in Malignant Glioma |
| Q34989089 | Role of miR-10b in breast cancer metastasis |
| Q33559304 | Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. |
| Q38027227 | Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy |
| Q59798408 | SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines |
| Q36179166 | Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma |
| Q34676929 | Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes |
| Q38237392 | Stem cell delivery of therapies for brain disorders. |
| Q83381970 | Stromal miR-320 keeps an oncogenic secretome in check |
| Q42289696 | Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR. |
| Q36866612 | TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells |
| Q45743838 | Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside. |
| Q28287476 | Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation |
| Q38584755 | Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders. |
| Q37736255 | Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma |
| Q37210093 | The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer |
| Q99591126 | The Role of Exosomes in Stemness and Neurodegenerative Diseases-Chemoresistant-Cancer Therapeutics and Phytochemicals |
| Q36268915 | The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy |
| Q37344777 | The locus of microRNA-10b: a critical target for breast cancer insurgence and dissemination |
| Q35014682 | The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival |
| Q55463784 | The many functions of microRNAs in glioblastoma. |
| Q34657471 | The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma |
| Q90169615 | The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma |
| Q30417554 | The miR-99 family regulates the DNA damage response through its target SNF2H |
| Q33728363 | The microRNA and messengerRNA profile of the RNA-induced silencing complex in human primary astrocyte and astrocytoma cells |
| Q37082176 | The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis |
| Q36898251 | The microRNA-148/152 family: multi-faceted players |
| Q45901790 | The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab. |
| Q38155656 | The molecular landscape of diffuse glioma and prospects for biomarker development |
| Q24629056 | The role of miR-26 in tumors and normal tissues (Review) |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q37601781 | The role of microRNAs in endometriosis and associated reproductive conditions |
| Q30428370 | The role of microRNAs in glioma initiation and progression |
| Q33937611 | The top cited articles on glioma stem cells in Web of Science |
| Q33744491 | The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas |
| Q35876143 | Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival. |
| Q34590225 | Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis |
| Q34518462 | Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas. |
| Q37269315 | Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma |
| Q33784406 | Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a |
| Q34998307 | Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer |
| Q35993546 | Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer |
| Q34014258 | Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes |
| Q49790324 | [MicroRNA-26a and Tumor]. |
| Q36300857 | cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a |
| Q89537480 | miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway |
| Q46272050 | miR-148a-3p Mediates Notch Signaling to Promote the Differentiation and M1 Activation of Macrophages |
| Q89511641 | miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model |
| Q47380679 | miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer |
| Q21091130 | miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics |
| Q50290153 | miR-26A microRNAs bind PTEN mRNA |
| Q39135735 | miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. |
| Q48344914 | miR-26a promoted endometrial epithelium cells (EECs) proliferation and induced stromal cells (ESCs) apoptosis via the PTEN-PI3K/AKT pathway in dairy goats |
| Q92761624 | miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2 |
| Q34981594 | miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer |
| Q92648780 | miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN |
| Q38962553 | miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2. |
| Q40328958 | miR-718 represses proinflammatory cytokine production through targeting phosphatase and tensin homolog (PTEN). |
| Q42182365 | miR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6. |
| Q39254996 | miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications |
| Q24598174 | miRNA and vascular cell movement |
| Q26781836 | miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks |
| Q38824458 | miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics |
| Q42563520 | miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma |
| Q34243937 | miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. |
| Q24628889 | miRNAs in human cancer |
| Q35684366 | microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma. |
| Q89720471 | microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy |
| Q27693891 | microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer |
| Q37592046 | microRNAs in gliomas: small regulators of a big problem |
Search more.